OneLife Launches PureOne, the World’s Best and Most Sustainable Home and Office Air Purifier, at CES 2020
LAS VEGAS, Jan. 7, 2020 /PRNewswire/ -- OneLife GmbH, makers of disruptive technologies to address the pollution crisis, today announced the...
Staff
Top PR and Marketing Posts from the Amendola Blog in 2019
SCOTTSDALE, Ariz., Jan. 7, 2020 /PRNewswire/ -- PR and marketing pros looking for some inspirational reading are invited to check...
Signant Health Partners with Propeller Health to Gather Accurate Data on Asthma and COPD Medication Use
PHILADELPHIA, Jan. 7, 2020 /PRNewswire/ -- Signant Health announced today a partnership to connect TrialMax®, the industry-leading electronic Clinical Outcome...
ANDE Corporation Is Honored with CES 2020 Innovation Award
WALTHAM, Mass. and LONGMONT, Colo., Jan. 7, 2020 /PRNewswire/ -- ANDE Corporation (https://www.ande.com/), the global leader in Rapid DNA Human Identification,...
New Initiative Provides Personalized Fertility Consultation in the Comfort of Your Home
PARSIPPANY, N.J., Jan. 7, 2020 /PRNewswire/ -- Ferring Pharmaceuticals and CCRM today announced the launch of Fertility House Calls, in the Greater...
RedHawk Engages Valerie Allen Public Relations
LAFAYETTE, Louisiana, Jan. 7, 2020 /PRNewswire/ -- RedHawk Holdings Corp. (OTC: SNDD) ("RedHawk" or the "Company") a diversified holding company engaged in...
Bayer and Evotec Form New Strategic Alliance Focusing on Polycystic Ovary Syndrome
NEW FIVE-YEAR, MULTI-TARGET ALLIANCE AIMS TO TRANSLATE FIRST-IN-CLASS SCIENCE AND DRUG DISCOVERY INTO NEW DRUGS FOR POLYCYSTIC OVARY SYNDROME PARTNERS...
Sphingotec Transforms into End-To-End Diagnostic Solutions Provider and Exclusively Represents Nexus Dx IB10 Immunoassay Portfolio
Following the acquisition and integration of former Samsung subsidiary Nexus Dx Inc., sphingotec becomes a fully integrated diagnostic solutions provider...
Healthy Hives 2020 Hosts Symposium at American Beekeeping Federation Conference
ST. LOUIS, Jan. 8, 2020 /PRNewswire/ -- Healthy Hives 2020, a multi-year, $1.3 million research initiative of Bayer and Project...
Streamline Health(R) Reports Third Quarter 2019 Revenues of $5.8 Million; ($0.2 million) Net Loss; Adjusted EBITDA of $1.3 Million
Total Revenues For First Three Quarters of $15.9 Million; ($0.5 Million) Net Loss; Adjusted EBITDA of $2.7 Million ATLANTA, GA...
Hepion Pharmaceuticals Presents Update on CRV431 Nonclinical Studies at NASH-TAG 2020 Conference
EDISON, NJ / ACCESSWIRE / January 8, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focused on the development...
REVIAN® Inc. Announces Issuance of Landmark Patent Covering the Use of Light to Stimulate the Body to Heal Itself
Leads to first all-LED medical device that regenerates hair. No chemicals. No pills. Just light. DURHAM, N.C.--(BUSINESS WIRE)--REVIAN Inc. (formerly...
Dr. Jan McBarron to Speak at “Ciao Bella” Luncheon
Dr. Jan McBarron will speak at a luncheon hosted by The Giving Store on January 13, 2020 HENDERSON, NV /...
Healthcare Solutions Holding, Inc., a Wholly Owned Subsidiary of Healthcare Solutions Management Group, Inc., (OTC Pink: VRTY) on Importance of Customer Service-Based Approach for Private Practices and Smaller Hospitals
NEW YORK, NY / ACCESSWIRE / January 8, 2020 / Healthcare Solutions Holdings, a medical service and device company focused...
Scott Patrick Carson Launches Scholarship Program
The Scott Patrick Carson Scholarship Program will offer two scholarships of $1,000 each PARK CITY, UT / ACCESSWIRE / January...
Allysta Pharmaceuticals, Inc. Doses First Patient with ALY688 Ophthalmic Solution in Phase 1/2a Dry Eye Study
SAN MATEO, CA / ACCESSWIRE / January 8, 2020 / Allysta Pharmaceuticals, Inc. (Allysta) today announced dosing of the first...
Arcutis Announces Enrollment of First Patients in Two Pivotal Phase 3 Clinical Trials Evaluating ARQ-151 as a Potential Once Daily Topical Treatment for Plaque Psoriasis
ARQ-151 potential "Best in Class" topical PDE4 inhibitor Plaque psoriasis affects approximately 8.6 million patients in the U.S. Phase 3...
Jaguar Health Announces that Published Study Indicates Crofelemer Could be a Treatment Option for Abdominal Pain Associated with Diarrhea-Predominant Irritable Bowel Syndrome
SAN FRANCISCO, CA / ACCESSWIRE / January 8, 2020 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), today...
Ventura Cannabis and Wellness Corp. (VCAN) Releases Preliminary Quarterly Financial Highlights for the Quarter Ending November 30, 2019; Posts Annualized Organic Growth Rate of 92%
Not for distribution to United States newswire services or for dissemination in the United States. all figures in Canadian dollars...
Angle PLC Announces Notice of Results
ANGLE plc ("the Company") Notification of Interim Results and Webcast GUILDFORD, SURREY / ACCESSWIRE / January 8, 2020 / ANGLE...